BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 36875356)

  • 1. Post-acute COVID-19 symptom risk in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis.
    Yuan N; Lv ZH; Sun CR; Wen YY; Tao TY; Qian D; Tao FP; Yu JH
    Front Public Health; 2023; 11():1112383. PubMed ID: 36875356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis.
    Fernández-de-Las-Peñas C; Palacios-Ceña D; Gómez-Mayordomo V; Florencio LL; Cuadrado ML; Plaza-Manzano G; Navarro-Santana M
    Eur J Intern Med; 2021 Oct; 92():55-70. PubMed ID: 34167876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of persistent symptoms after COVID-19 (long COVID): a meta-analysis of controlled studies in children and adults.
    Azzam A; Khaled H; Refaey N; Mohsen S; El-Emam OA; Dawood N; Ahmed HA; Soliman OA; Mostafa S; Ramadan H; Mosa M; Elmowafy AOI; Rizk SMA; Zaki A; Hussien M; Ahmed A; Ezzat AA; Hassan FE
    Virol J; 2024 Jan; 21(1):16. PubMed ID: 38212781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months.
    Karaarslan F; Güneri FD; Kardeş S
    Clin Rheumatol; 2022 Jan; 41(1):289-296. PubMed ID: 34713356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review.
    Nasserie T; Hittle M; Goodman SN
    JAMA Netw Open; 2021 May; 4(5):e2111417. PubMed ID: 34037731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent symptoms among post-COVID-19 survivors: A systematic review and meta-analysis.
    Rochmawati E; Iskandar AC; Kamilah F
    J Clin Nurs; 2024 Jan; 33(1):29-39. PubMed ID: 36426658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-COVID in children and adolescents: a systematic review and meta-analyses.
    Lopez-Leon S; Wegman-Ostrosky T; Ayuzo Del Valle NC; Perelman C; Sepulveda R; Rebolledo PA; Cuapio A; Villapol S
    Sci Rep; 2022 Jun; 12(1):9950. PubMed ID: 35739136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences.
    Rahmati M; Udeh R; Yon DK; Lee SW; Dolja-Gore X; McEVoy M; Kenna T; Jacob L; López Sánchez GF; Koyanagi A; Shin JI; Smith L
    J Med Virol; 2023 Jun; 95(6):e28852. PubMed ID: 37288652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-Year Health Outcomes in Hospitalized COVID-19 Survivors in China.
    Yang X; Hou C; Shen Y; Zhang M; Zhang K; Wang F; Liu Y; Ma X; Cheng L; Kang J; Hu B; Wang M; Zeng L; Wang Y; He Y; Cao G; Jiang J; Jones P; Cao B; Li L
    JAMA Netw Open; 2022 Sep; 5(9):e2231790. PubMed ID: 36107425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Headache as a COVID-19 onset symptom and post-COVID-19 symptom in hospitalized COVID-19 survivors infected with the Wuhan, Alpha, or Delta SARS-CoV-2 variants.
    Fernández-de-Las-Peñas C; Cuadrado ML; Gómez-Mayordomo V; Torres-Macho J; Pellicer-Valero OJ; Martín-Guerrero JD; Arendt-Nielsen L
    Headache; 2022 Oct; 62(9):1148-1152. PubMed ID: 36111527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Neurological Sequelae Among Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.
    Patel UK; Mehta N; Patel A; Patel N; Ortiz JF; Khurana M; Urhoghide E; Parulekar A; Bhriguvanshi A; Patel N; Mistry AM; Patel R; Arumaithurai K; Shah S
    Cureus; 2022 Sep; 14(9):e29694. PubMed ID: 36321004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.
    Premraj L; Kannapadi NV; Briggs J; Seal SM; Battaglini D; Fanning J; Suen J; Robba C; Fraser J; Cho SM
    J Neurol Sci; 2022 Mar; 434():120162. PubMed ID: 35121209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
    Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
    Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
    Fernández-de-Las-Peñas C; Rodríguez-Jiménez J; Cancela-Cilleruelo I; Guerrero-Peral A; Martín-Guerrero JD; García-Azorín D; Cornejo-Mazzuchelli A; Hernández-Barrera V; Pellicer-Valero OJ
    JAMA Netw Open; 2022 Nov; 5(11):e2242106. PubMed ID: 36378309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: A meta-analysis of the current literature.
    Fernández-de-Las-Peñas C; Navarro-Santana M; Gómez-Mayordomo V; Cuadrado ML; García-Azorín D; Arendt-Nielsen L; Plaza-Manzano G
    Eur J Neurol; 2021 Nov; 28(11):3820-3825. PubMed ID: 34327787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis.
    Lee JH; Yim JJ; Park J
    Respir Res; 2022 Sep; 23(1):233. PubMed ID: 36068582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent CD8
    LaVergne SM; Dutt TS; McFann K; Baxter BA; Webb TL; Berry K; Tipton M; Stromberg S; Sullivan BM; Dunn J; Henao-Tamayo M; Ryan EP
    Front Immunol; 2023; 14():1303971. PubMed ID: 38327763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.